NCT01803022View on ClinicalTrials.gov

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

CompletedOBSERVATIONAL
Enrollment

419

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Venous Thromboembolism
Trial Locations (1)

75010

Hopital Saint Louis, Paris

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY